Transcript Highlights:

• consent to collect your data in a standardized way.
• and data sharing, what are we talking about there?
• way to document that consent to treatment, any data collection, or any data sharing, and that's exactly
• First off, you asked about our data collection and data sharing, Representative Schofield.
• We all understand what that is, and then we're consenting to data collection and data sharing.

Bills: HB18, HB742, HB754, HB1644, HB2187, HB1887, HB 1275, HB37, HB1503, HB1699, HB1700, HB2735, HB1741, HB1731, HB1675, HB18, HB37

Keywords: rural health, hospital funding, healthcare access, mental health services, financial stability, human trafficking, first responders, health care, training, reporting, protection, trafficking prevention, medical assistant training, health care facilities, hospital compliance, clinic compliance, anti-retaliation, whistleblower protection, employee reporting, good faith report

Transcript Highlights:

• It simply makes clear that genetic data, whether obtained directly or indirectly, cannot be used to make
• It simply makes clear that genetic data, whether obtained directly or indirectly, cannot be used to make
• It is extremely important to note that genetic data is fundamentally different from traditional medical
• Genetic data is probabilistic, not diagnostic in the absence of symptoms.
• Given the historical disparities in health care and insurance access, do you ensure genetic data isn't

Keywords: 988, house, all

Transcript Highlights:

• It simply makes clear that genetic data, whether obtained directly or indirectly, cannot be used to make
• It is extremely important to note that genetic data is fundamentally different than traditional medical
• data.
• The data are clear: family history is sufficient for insurers to price risk, and genetic...
• The data are clear: family history is sufficient for insurers to price risk, and genetic data is probabilistic

Keywords: 987, senate, all

Transcript Highlights:

• your genetic data. your genetic data.
• consumers genetic data. consumers genetic data.
• Genetic data is not just about people. Genetic data is not just about people.
• data, and how the companies secured and stored genetic data and genetic material.
• something with a consumer's genetic something with a consumer's genetic data. data. data.

Keywords: 927, senate, all

Transcript Highlights:

• It simply makes clear that genetic data, whether obtained directly or indirectly, cannot be used to make
• It simply makes clear that genetic data, whether obtained directly or indirectly, cannot be used to make
• It is extremely important to note that genetic data is fundamentally different than traditional medical
• Genetic data is probabilistic, not diagnostic in the absence of symptoms.
• Given the historical disparities in health care and insurance access, do you ensure genetic data isn't

Summary: The committee heard several bills focused on privacy, accessibility, labor, and public safety. AB 1798 by Assemblymember Wilson would bar life and disability insurers from using non-diagnostic genetic information, including direct-to-consumer test results, in underwriting. Supporters argued the bill would protect privacy and encourage genetic testing, while insurers opposed it as unnecessary and said genetic data should be treated like other predictive health information. The bill passed the committee on a 7-0 vote and was held open for absent members. AB 2190 by Assemblymember Wallace would create website accessibility standards based on WCAG guidelines and add affirmative defenses intended to reduce serial litigation while improving access for people with disabilities. Disability advocates supported the measure as a needed civil-rights update, while business groups warned it could increase liability and create unclear compliance obligations. The bill passed 9-0 and was sent to Appropriations. AB 2721 by Assemblymember Carrillo would require hotels to post notice when they know or should know that U.S. Customs and Border Protection or ICE are using the premises, with supporters saying workers and guests deserve transparency and safety. Hotel and business groups opposed it, citing privacy, liability, and concerns about interfering with federal operations. The committee voted 6-2 to pass the bill to Appropriations, with the roll left open. AB 2027 by Assemblymember Ward would restrict employers from using worker data to train AI systems that replace workers and limit sharing of worker data for automation; labor groups supported it and business and public-sector groups opposed it as too broad. The bill passed 7-2 to Appropriations, with the roll left open. The committee also heard AB 1837 by Assemblymember Mark Gonzalez, which would extend and tighten privacy rules for transit agencies’ use of forward-facing cameras to enforce bus-lane violations; supporters said the cameras improve transit flow and safety, and the bill was presented with amendments, though no final vote is reflected in the transcript excerpt.

Transcript Highlights:

• data ...requires by creating genetic data privacy protections for all Vermonters.
• Genetic data is not just about people; it is people.
• Genetic data is not just about people; it is people.
• Our genetic data is who we are in the most intimate sense.
• data once it was Certain types of genetic data, once it was sold or breached, could not be cured.

Keywords: 927, senate, all

Transcript Highlights:

• I am a local cancer genetic counselor and president of the Arizona Genetics Alliance.
• I'm a local cancer genetic counselor and president of the Arizona Genetics Alliance.
• Genetic counseling saved my life.
• We had our own genetic counselor.
• That data already exists.

Keywords: 1182, all

Summary: The committee heard House Bill 2433, which would require insurers offering Medicare supplement policies to people 65 and older to also offer them to Medicare beneficiaries under 65 with ALS or end-stage renal disease, with enrollment periods and premium protections tied to 65-year-old rates. Supporters, including dialysis and ALS advocates, said the bill would help a small population facing high out-of-pocket costs and could improve access to transplants and care; opponents argued it would shift costs onto older seniors and raise Medigap premiums. The committee recommended the bill do pass on a 12-0 vote. The committee also heard House Bill 2593, appropriating $1.5 million to the University of Arizona for the Arizona Perinatal Psychiatry Access Line. The sponsor and physicians testified that the line helps obstetric and pediatric providers quickly consult on perinatal depression, postpartum psychosis, suicidality, and other mental health crises, improving outcomes for mothers, children, and families and reducing costly emergency and crisis care. The bill received a do pass recommendation on a 10-1 vote. House Concurrent Resolution 2013, proclaiming June 2026 as Celebrate Life Month, drew emotional testimony from a young woman with spina bifida and another speaker supporting the sanctity of life. Some members objected that the state should focus on practical supports such as paid leave, child care, and health care access, while others supported the resolution as a statement of human dignity. The resolution passed the committee 7-5. The committee then approved House Bill 4010, creating a Board of Genetic Counselors and licensure standards, after testimony from genetic counselors and a patient advocate about the need for qualified counseling and better access; it passed 11-1. Later, the committee approved House Bill 2196, which would require pharmacy benefit managers to reimburse non-affiliated pharmacies at least their acquisition cost and pay a dispensing fee, and establish an appeals process. Independent pharmacists and their coalition said PBM practices are driving closures and unfairly favor affiliated pharmacies, while PBM and employer representatives warned of major cost increases and said the bill would interfere with private contracts; the bill passed 11-1. The committee also adopted a strike-everything amendment to House Bill 2182 requiring insurers and health plans to report claims denial and prior authorization data to DIFI, and then gave the amended bill a 12-0 do pass recommendation. Finally, the committee approved House Bill 2189, directing the Board of Nursing to update rules for licensed health aides and collect annual data, with the sponsor and board staff saying it would help implement routine ventilator care in the home; it passed 12-0. The committee then began hearing House Bill 2404, a strike-everything amendment on inter-facility transports for behavioral health patients, but the transcript cuts off before action on that bill.

Transcript Highlights:

• The first is House Bill 639, House Bill 639, which is an act relating to genetic data privacy, the Committee
• House Bill 639 is an act relating to genetic data privacy.
• We agreed with them on a 30-day cure period for all of the business activities of these genetic data
• The bill was genetic data privacy.
• <00:03:05.840> data<00:03:06.080> privacy activities of these genetic data privacy

Keywords: 926, house, all

Summary: The House took up two committee of conference reports. On House Bill 639, relating to genetic data privacy, members suspended the rules for immediate consideration and adopted the conference report. The conference compromise settled a dispute over cure periods by allowing a 30-day cure period for business activities of genetic data privacy businesses, effective January 1, 2027, with the cure period lasting 18 months and then repealing on June 30, 2028. A House member explained the House had sought a narrower cure period than the Senate, and the final report was adopted by voice vote. The House then suspended the rules to take up House Bill 710, relating to defining electricity generating facilities, and also adopted that conference report by voice vote. The bill updates the definition of a “single plant” to focus on facilities using the same point of interconnection, clarifies the change is not retroactive and applies only to new permit and certificate applications, and adds a Department of Public Service report on farmland conversion to solar by January 15, 2027. It also expands Public Utility Commission hiring authority for complex renewable energy cases, creates a decommissioning fund for abandoned clean energy facilities, requires the PUC to report on the decommissioning fee formula, and sets an effective date of July 1, 2026. The conference committee reported unanimous support. After the two reports were adopted, the House stood at ease, then returned briefly for announcements. Members offered remarks thanking the Speaker for her service after news she would not run again, invited members to view an end-of-year legislative slideshow, and wished a member from Randolph a happy birthday. The House then adjourned until the next day at 10:00 a.m.

Transcript Highlights:

• H-5122, an act prohibiting genetic discrimination.
• they may have based on genetic testing.
• And it forces people to delay or avoid genetic testing.
• testing data.
• Access to genetic testing data. There's no business necessity here, only a question of fairness.

Keywords: 995, all

Summary: The Joint Committee on Financial Services held a fully virtual public hearing after a blizzard and state emergency closed the State House and created travel and cleanup concerns. Chairs Senator Paul Feeney and Representative James Murphy opened by thanking first responders and committee staff for making the hearing possible and noted that several members attended remotely. The committee heard testimony on three bills: H.5112, An Act Prohibiting Genetic Discrimination; H.4914, An Act Relative to the Massachusetts Uniform Commercial Code; and S.2921, An Act Relative to Travel Insurance. Most of the testimony focused on H.5112. Representative Dave Rogers and his constituent Robin Biggs testified in support of H.5112, describing gaps in federal genetic nondiscrimination law that do not cover life, long-term care, or disability insurance. Biggs shared her experience as a BRCA2 mutation carrier and said genetic knowledge helped her take preventive steps, but that people fear testing because insurers may use results against them. Lindsay Jack of the ALS Association and Lisa Schlager of FORCE also supported the bill, arguing that it would encourage preventive care, research participation, and fairer underwriting without harming insurance markets. They said insurers could still use medical history and diagnoses, but not genetic test results alone. Committee members asked questions about whether insurers currently request genetic testing and how such information is used in underwriting. Testifiers said the information is routinely asked for or found in medical records, but the bill would prohibit its use in coverage decisions and would prevent insurers from requiring testing. No votes were taken. After testimony concluded and no additional witnesses came forward, the chairs closed the hearing and adjourned the meeting by unanimous voice vote.

Transcript Highlights:

• From the managing entities and other sources through numerous reports and data points.
• Many of the existing reports are based on age data or limited visibility.
• It also clarifies key data points that must be reported.
• For those of you who don't know, Duchenne is a severe and sadly progressive genetic disorder.
• Members, if you heard me talk about this topic before, you... ...with genetic disorders.

Summary: The Health Care Budget Subcommittee met and took up four bills. First, CS/HB 633 by Rep. Koster on managing entity reporting and transparency for behavioral health services was amended to clarify reporting requirements and timing, and to address the bill’s fiscal implementation through conferencing. Members and one public speaker supported the measure, emphasizing accountability and better use of state funds. The bill was reported favorably. Next, CS/HB 531 by Rep. Hunschofsky on background screenings was amended with a strike-all that would require ACCA to create a public webpage with screening education, level-two screening standards, and a searchable catalog of positions requiring screening. Because the amendment changed the bill’s relating-to clause, the chair noted it would be temporarily postponed under House Rule 7.11D and returned to the committee later. The committee then heard HB 1089 by Rep. Booth, which adds Duchenne muscular dystrophy to the recommended newborn screening panel, subject to appropriation. A parent testified in strong support, describing the benefits of earlier diagnosis and treatment, and several members spoke in favor. The bill was reported favorably. Finally, CS/HB 907 by Rep. Anderson created the Sunshine Genetics Program, an opt-in newborn whole-genome sequencing program, and established the Florida Institute for Pediatric Rare Diseases at FSU and a Sunshine Genetics Consortium. An amendment made funding contingent on appropriations and added Nicholas Children’s Hospital and Florida International University to the consortium board. After supportive testimony and debate, the bill was also reported favorably. The meeting then adjourned.

Transcript Highlights:

• We have improved the productivity in genetics and genomics 40% using AI.
• externally with any data centers whatsoever.
• You don't run out any data from a data center?
• The more data we have and the more data we're able to train, whether it's a large learning model or language
• And we've got providers that cannot include identifiable data in the provenance data about a person unless

Bills: SB1786

Keywords: artificial intelligence, content verification, provenance data, transparency, digital content, 1182, all

Transcript Highlights:

• The Sunshine Genetics Act supports newborn whole genome sequencing across Florida.
• , patient advocacy groups, and genetic researchers from Florida and beyond.
• And so we, from that, chose a different path of data mining, The population.
• So we did start with available data.
• Some of the other clinical care data is less available. Thank you, Madam Chair.

Summary: The Health Professions and Program Subcommittee met with a quorum present and received a briefing from Melissa Jordan, Assistant Deputy Secretary for Health and chair of the Florida Rare Disease Advisory Council (ARDAC). Jordan explained that rare diseases affect fewer than 200,000 people each individually, but together impact an estimated 2.3 million Floridians. She reviewed ARDAC’s structure, its three subcommittees, and its 2025 legislative report recommendations, which focused on expanding Florida-specific data, disaster preparedness, state agency coordination, insurance oversight, provider education, faster diagnostic tools, research collaboration, and establishing centers of excellence. She also highlighted ARDAC’s work with other states and its effort to build an online repository of resources for families and providers. Jordan discussed the Andrew John Anderson Pediatric Rare Disease Grant Program, funded at $500,000 annually, which supported research awards at Florida State University and the University of Miami in 2024 and another University of Miami project in 2025. She also described House Bill 907 and the Sunshine Genetics Act pilot program, which created the Florida Institute for Pediatric Rare Diseases at FSU and a newborn whole-genome sequencing pilot to screen volunteer infants for hundreds of conditions beyond traditional newborn screening. The institute will include research, training, clinical care, a diagnostic lab, genome editing capacity, and a sequencing pilot overseen by a board, consortium, and steering committee. Members asked about interstate collaboration, the scope of data collection beyond Medicaid, how the council reduces family financial burdens, how families and providers can learn about available resources, and how ARDAC measures effectiveness. Jordan said Florida has learned from other states’ survey-based approaches and instead is using administrative data sources such as Medicaid, hospitalizations, emergency department visits, birth and death certificates, with more clinical data to be added over time. She said success is tracked through annual reports, ongoing work plans, and quarterly research reports that measure progress, patient enrollment, treatment outcomes, and potential follow-on funding. The meeting concluded after the presentation and questions, and the subcommittee adjourned without further business.

Transcript Highlights:

• different species of compounds because it's all done by genetic sequencing.
• So, like I was saying, genetic assay attempts to quantify yeast and mold by genetic sequence and I got
• For genetic assay of this vast number of species that obviously don't have the same genetic sequence,
• , but additionally, if citizen scientists, data analysts, and other people can look at this data if it
• We ought to be able to analyze this data in my opinion.

Keywords: 914, all

Transcript Highlights:

• public education and we uh take data public education and we uh take data privacy<01:18:50.280><
• Do you see this kind of data classified as medical data or student data? It's medical data.
• How am I due to genetics? How are you classifying a female via genetics? Chair: Thank you.
• the genetics of using to determine the genetics of someone<01:27:59.639> that<01:27:59.719>
• female how am I due to genetics female how am I due to genetics how<01:28:24.960> are<01:

Keywords: 1183, house

Transcript Highlights:

• The Sunshine Genetics Program is not only the right thing to do for families, it will also save money
• Let me say a few points on the data here, the why.
• Well, I think the answer to that is that we have more data today than we had two years ago.
• Let me say a few points on the data here, the why.
• Well, I think the answer to that is that we have more data today than we had two years ago.

Summary: The Education Administration Subcommittee heard and approved four bills focused on school safety, student health, and classroom environment. HB 1403, Safety of Students, would expand Guardian program participation to child care facilities, require substitute teachers to receive campus safety protocols, and allow limited exceptions for certain CTE classrooms; it drew supportive testimony from school safety and education groups and passed 16-0. PCS for HB 907, the Sunshine Genetics Act, would create the Florida Institute for Pediatric Rare Diseases at FSU and launch an opt-in newborn whole-genome screening program funded with $20 million; supporters said it could speed diagnosis, save lives, and reduce health care costs, and it passed 17-0. HB 949 would prohibit student use of wireless communication devices during the full school day, while allowing districts flexibility in implementation and medical exceptions; supporters cited distraction and bullying data, and the bill passed 17-0. The committee also approved HB 723, the Type 1 Diabetes Early Detection Program, which requires the Department of Health to provide school-based informational materials to parents and guardians about early warning signs, risk factors, and screening for type 1 diabetes. An amendment broadened the notification to include voluntary pre-K, kindergarten, and first grade and shifted the annual notice to September 30. Testimony in support came from diabetes advocates and pediatric groups, and members spoke about personal experiences with diabetes and the value of earlier education. The bill passed 17-0 after the amendment was adopted. Across the meeting, members from both parties generally praised the bills as bipartisan efforts to improve student safety, health, and learning conditions. Several members raised questions or concerns about implementation details, including school guardian tracking, cell phone pouches and emergency access, and how the diabetes notice would be distributed, but no bill faced opposition in committee. All four measures were reported favorably.

Transcript Highlights:

• The prevalence of this genetic mutation and the potential adverse effects related to that genetic mutation
• There was no data to make that decision.
• there, we've got 10 years of data now.
• Data-driven decision.
• So, there's no data there.

Bills: HB3552, HB2984, HB4124, HB3934, HB3448, HB3131, HB4200, HB4201, HB3011, HB1912, HB3380, HB3881, HB3538, HB3851, HB3907, HB4430, HB4431, HB4457

Keywords: childcare, differential pricing, Department of Human Services, child care subsidy, licensed providers, emergency legislation, child care, subsidy program, annual report, program integrity, overpayments, ivermectin, over-the-counter medication, pharmacy immunity, healthcare access, FDA approval, prescription, public health, dentistry, licensing

Transcript Highlights:

• S. 248, an act relating to genetic data privacy, introduced by Senators Harrison and Plunkett.
• S. 248, an act relating to genetic data privacy. >> Now you've heard the first reading of the bill and
• <00:09:02.320> data S248 an act relating to genetic data S248 an act relating to genetic data
• <00:09:13.920> data S248, an act relating to genetic data S248, an act relating to genetic
• data privacy. privacy. privacy.

Keywords: 927, senate, all

Transcript Highlights:

• Limiting the translocation of the genetically diverse wolf pups into the...
• We need to... ...genetic diversity, because they came from so few animals.
• There's no data showing the distinct populations that is part of the historical range.
• The third location is that they want one on... ...necessarily the genetics of it.
• by wildlife managers to maintain genetic diversity and prevent dangerous genetic bottlenecking.

Bills: SB1075, SB1144, SB1280

Keywords: foreign ownership, land sales, review commission, national security, property rights, veterinary technicians, certification, education alternative, Arizona Revised Statutes, veterinary education, Mexican gray wolf, Mexican wolf, Mexican gray wolf puppies, Arizona Game and Fish Commission, Arizona Game and Fish Department, endangered species, wolf reintroduction, wolf translocation, cross-fostering, wildlife management

Transcript Highlights:

• sell and monetize that data.
• So any data... that I could give you would be inadequate.
• data itself shows.
• So, as a parent who had a child diagnosed with a genetic cancer, although it was not genetic, medicine
• The FDA, by its nature, amasses significant data.

Bills: SB95, SB268, SB493, SB619, SB660, SB922, SB984, SB1098, SB1188, SB1307, SB1332, SB1822

Keywords: immunization, written informed consent, civil liability, health care provider, vaccine compensation, administrative penalty, health care, licensing, complaint procedure, disciplinary action, law enforcement, pharmacy benefit manager, PBM, gag clause, prescription drug pricing, out-of-pocket cost, cash price, pharmacist, pharmacy, prescription drug benefit

Transcript Highlights:

• The $50 was due to a national data point around average application fees.
• management and data sharing and confidentiality around that data.
• We have that data. It's very possible we have that data. Madam Chair, Mr.
• And so I think that was part of the reason for the genetic testing.
• And that's a different alternative than doing genetic testing.